期刊文献+

血红蛋白水平对宫颈癌患者放射治疗疗效的影响 被引量:4

Impact of Hemoglobin(Hgb) Level on Therapeutic Effect of Radiotherapy in Cervical Cancer Patients
暂未订购
导出
摘要 目的回顾性分析宫颈癌患者血红蛋白(Hgb)水平对根治性放射治疗预后的影响。方法经病理诊断证实宫颈癌患者862例行根治性放射治疗,外照射采用8MV-X射线前后二野或盒式四野照射方法,剂量(30~36)Gy后行宫旁淋巴引流区推量照射(18~24)Gy;宫颈腔内近距离放疗(6~7)Gy/次×(5~6)次;放疗总剂量:A点(60~70)Gy,B点(50~55)Gy。放疗中对症止血治疗。结果不同程度贫血对宫颈癌放疗的局部控制率和远期疗效有明显影响。结论 Hgb浓度影响宫颈癌的局部控制率和远期生存率,放疗前尽量提高患者Hgb水平至100g/L以上。 Objective To investigate the impact of the cervical cancer patients'hemoglobin(Hgb)level on the prognosis of radical radiotherapy by retrospective analysis.Methods Eight hundred and sixtytwo pathologically verified patients with cervical cancer were treated with radical radiotherapy,8MV-X ray was used for external radiation with a dose of(30~36)Gy by anterior-posterior two-fields or boxlike four-fields radiation technique,and then the lymphatic drainage area beside pelvic was added a dose of(18~24)Gy.Meanwhile,the patients were also treated with after loading radiotherapy with the dose of(6~7)Gy/fraction×5-6 fraction.The total dose of A point is(60~70)Gy,B point is(50~ 55)Gy.During the radiotherapy,we gave the patients symptomatic treatment.Results The anemias in different degree have significant impact on the local control rate and long-term survival rate of the cervical cancer patients who were treated with radiotherapy.Conclusion The concentration of Hgb influences the local control rate and long-term survival rate of cervical cancer patients.We should elevate the patients'Hgb level higher than 100g/L before radiation.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第11期1300-1302,共3页 Cancer Research on Prevention and Treatment
关键词 宫颈癌 放射治疗 血红蛋白 预后 Cervical cancer Radiotherapy Hemoglobin Prognosis
  • 相关文献

参考文献6

  • 1Dische S. Radiotherapy and anaemia the clinical experience[J].Radiother Oncol, 1991,20 (Suppl1) : 35-40.
  • 2Grogan M, Thomas GM, Melamed I, et al. The important of hemoglobin levels during radiotherapy for carcinoma of the cervix[J]. Cancer, 1999,86(8) : 1528-1536.
  • 3程晶,伍钢,彭纲,黄晶.重组人红细胞生成素治疗恶性肿瘤贫血的临床观察[J].肿瘤防治研究,2005,32(8):511-512. 被引量:7
  • 4Kapp KS,Poschauko J ,Tauss J ,et al. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma[J].Int J Radiat Oneol Biol Phys ,2005, 62(5) : 1399-1404.
  • 5Henke M, Laszig R, Rude C, et aL. Erythropoietin to treat heat and neck cancer patients with anaemia undergoing radiothera py: randomised, douhleblind, placebo-controlled trial [J]. Lan cet, 2003,362 ( 9392 ) : 1255-1260.
  • 6杨成民 张天泽 徐光炜.肿瘤患者的输血[A].张天泽,徐光炜.肿瘤学[C].天津:天津科学技术出版社,1996.2645—2659.

二级参考文献11

  • 1Dai CH , Price JO , Brunner T , et al. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon to produce erythroid cell apoptosis[J].Blood ,1998 , 91(4):1235-1242.
  • 2Feelders RA , Vreugdenhil G, Eggermont AM, et al. Regulation of iron metabolism in the acute phase response : interferon gamma and tumor necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transfertin receptors in cancer patients[J]. Eur J Clin Invest, 1998,28(7) : 520-527.
  • 3Rice L , Alfrey CP , Driscoll T , et al. Neocytolysis contributes to the anemia of renal disease[J]. Am J Kid Dis, 1999,33 ( 1 ) : 59-62.
  • 4Abels RI ,Larbolt KM, Krantz , et al. Recombinant human erythropietin(rHuEPO) for the treatment of the anemia of cancer ; in Murphy MJ Jr(ed ): blood cell growth factors :Their present and future use in hematology and oncology[M].Procceings of the Beijing Symposium. Dayton. Ohio, Alpha Med Press ,1991. 121.
  • 5Tsukuda M, Yuyama S, Kohno H, et al. Effectiveness of weekly subcutaneous recombinant human erythropoietin administration for chemotherapy-induced anemia[J]. Biotherapy, 1998, 11(1): 21-27.
  • 6Cheung WK, Goon BL , Guilfoyle MC , et al . Pharmacokinetics and pharmacdynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects[J]. Clin Pharmaclo Ther , 1998,64 (4) :412-416.
  • 7Glaspy J. The impact of epoetin alfa on quality of life during cancer chemotherapy : A fresh look at an old problem[J]. Serain Hematol, 1997, 34 (3, suppl 2): 20-26.
  • 8David H. Supplemental Iron: A Key to Optimizing the Response of Cancer-Related Anemia to rhuEPO? [J]. The Oncologist, 1998,3(4): 275-278.
  • 9Littlewood T J. Erythropoietin for the treatment of anemia associated with hematological malignancy [J]. Hematol Oncol,2001, 19(1): 19-30.
  • 10Faquin WC , Schneider TJ , Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production[J]. Blood,1992 , 79(8): 1987-1994.

共引文献12

同被引文献41

  • 1罗仪,王剑,赵昌银,陈双郧.35岁以下宫颈癌患者的分子病理高危因素分析[J].中国肿瘤临床,2006,33(21):1221-1224. 被引量:6
  • 2金志红,廖革望,江宁.复发、转移的年轻妇女宫颈癌91例临床分析[J].实用癌症杂志,2006,21(5):502-503. 被引量:6
  • 3孙.燕,石远凯.临床肿瘤内科手册[M].第5版.北京:人民卫生出版社,2007:142-624.
  • 4Rose PG,Bundy BN,Watkins EB,et al : Concurrent cisplatin based chemoradiation improves progression-free and overall survival in advanced cervical cancer. Results of a randomized Gynecologic On- cology Group study[J]. N Engl J Med,1999,340:1144.
  • 5Fyles A, Keane TJ, Barton M, Simm J]The effect of treatment du ration in the local control of cervix cancer[J]. Radiother On- col1992,25 :273.
  • 6Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organiza- tion for Research and Treatment of Cancer (EORTC)[J]. Int J Radiat Oncol Biol Phys , 1995,31 (5) :1341 -1346.
  • 7loka A, Tsukuma H, Ajiki W, et al. Influence of age on cervi- cal smwival in Japan[J]. Jpn J Clin Oncol, 2005, 35 (8) : 464 - 469.
  • 8Grogan M, Thomas GM, Melamed I, et al. The important of hemoglobin levels radiotherapy for carcinoma of the cervix [ J]. Cancer, 1999, 86 ( 8 ) : 1528 - 1536.
  • 9Lin YC, Kudelka AP, Lawrence D, et al. Transcatbeter arteri- al embolization for the control of life-threatening pelvic hemor- rhage in a patient with locally advanced cervix carcinoma[ J]. Eur J Gynaecol Oncol, 1996, 17 ( 6 ) :480 - 483.
  • 10Kramer SC, Gt:rich J, Rilinger N, et ah Interventional treatment of hemorrhages in advanced cervical earcinoma[ J]. Radiologe,1999, 39(9) :795 -798.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部